2025.09. 06 把越来越多且越来越高端的研发制造搬到中国实现本土化，这是全球光学巨头蔡司这些年"一以贯之"的行动。 从德国总部决定在中国自购土地建立工厂，到运营一周年后实现营收翻番，成为全球显微镜出货量最大的工厂，蔡司苏州研发制造基地（下称"蔡司苏州"）的持 续进阶成为外资在华持续加码的最新例证。 面对全球经济下行和地缘政治冲突等不确定性加剧，全球实际外国直接投资（FDI）持续两位数下降，中国吸引外资亦不乏挑战，但中国始终是跨国企业不可能 忽视的重要市场。随着中国制造在全球价值链上的升级，外资面临的挑战与机遇并存。 高端产品在华本土化 本文字数：2493，阅读时长大约4分钟 作者 | 第一财 经 缪琦 作为蔡司集团在华本土化战略的核心支点，蔡司苏州开业一年后，较此前实现营收同比翻番，达7.6亿元人民币。与此同时，三款高端显微镜本土化制造落地，标 志着蔡司成为业界首个在激光共聚焦和场发射扫描电子显微镜领域实现在华生产交付的国际厂商，也由此实现了核心显微镜产品线在中国的全面"本土化"。 "中国是蔡司在全球最大的市场，增速也在全球领先。"蔡司大中华区首席运营官谢磊在9月5日的开业一周年庆典上告诉第一财经，苏 ...

Core Viewpoint - Jiaxing Zhitong Technology Co., Ltd. has completed a multi-million A+ round financing, primarily aimed at the registration and market promotion of its full range of surgical and ophthalmic microscope products domestically and internationally [1] Company Overview - Founded in 2020, Zhitong Technology's founding team is led by a Tsinghua University academic and has established a solid foundation in stereoscopic vision [1][4] - The company focuses on visual imaging, intelligent perception, and decision-making innovation technology for microsurgery, aiming to become a leader in the fine surgical development industry and a global provider [1][6] Product Development - Zhitong Technology has launched six high-end imaging and intelligent series products under its own brand AINNOVI®, leading the domestic mid-to-high-end surgical microscope market [2][4] - The high-end 3D external viewing microscope has received a Class II medical device registration certificate, addressing the shortcomings of traditional optical microscopes and meeting the upgrade needs of existing medical institutions [2][4] Market Trends - The surgical microscope industry is undergoing a transformation from traditional optical microscopes to a "optical + digital + intelligent" integrated platform, representing a potential market worth hundreds of billions [2][6] - The new external viewing systems significantly enhance the safety and efficiency of minimally invasive procedures, supporting the rapid development of functional protection and precise repair in surgery [2][6] Future Prospects - With the gradual approval of high-end imaging products and intelligent surgical microscopes, Zhitong Technology is set to inject new energy into the global surgical microscope market, accelerating the digital and intelligent development trends in the industry [6][8] - The company aims to contribute to the localization of mid-to-high-end surgical microscopes and the technological upgrade of the global surgical microscope industry [7][8]

Core Points - The "zero tariff" import policy for medical devices and drugs in Hainan Boao Lecheng International Medical Tourism Pilot Zone has successfully facilitated the import of domestically listed medical devices, marking a significant milestone in the implementation of this tax incentive policy [1] - The policy allows for the exemption of import tariffs and value-added tax for registered medical institutions, medical education institutions, and pharmaceutical research institutes within the pilot zone, thereby enhancing the attractiveness of Hainan as a free trade port [1][2] Group 1 - The first successful import under the "zero tariff" policy involved a surgical microscope valued at 1.058 million yuan, resulting in a tax reduction of 137,500 yuan [1] - The policy covers two categories of medical devices: those not yet listed in China but available abroad, and those already listed domestically [1] - The implementation of this policy is expected to lower medical costs for patients and enhance the competitive edge of the free trade port by attracting advanced international medical technologies and products [1] Group 2 - As of June 2025, the cumulative import value under the "zero tariff" policy is projected to reach 130 million yuan, with tax reductions nearing 18 million yuan, indicating the growing impact of the policy [2] - The Boao Airport Customs is committed to promoting the policy and providing services to ensure that the benefits reach more medical institutions and patients [2]